Emergency use authorization for Johnson & Johnson's single-shot vaccine candidate could help speed deployment of COVID-19 vaccines. (Beth Israel Deaconess Medical Center, February 27, 2021)
Most COVID-19 vaccine reactions are similar to those of the flu shot. Learn more about the possible side effects and find answers to questions on allergies and fertility.
As public COVID-19 vaccinations begin, it’s important to understand Massachusetts' vaccine rollout plan and when you will be eligible to get vaccinated.
Findings suggest ECMO life-support therapy can improve odds of survival for patients critically ill with COVID-19. Learn more about this study. (Beth Israel Deaconess Medical Center, February 2, 2021)
Dr. Carter specializes in Internal Medicine and is an Assistant Professor for Harvard Medical School. He speaks directly to those who are hesitant to get the vaccine.
BILH Needham Heights primary care physician Dr. Perez-Lirio speaks about why she trusts the COVID-19 vaccine.
Beth Israel Lahey Health gastroenterologist Dr. Villafuerte Galvez talks about why he chose to get vaccinated and what he tells his patients.
We know our patients have questions about the availability, safety and effectiveness of COVID-19 vaccines. Here is the latest information available.
According to new trial data, Johnson & Johnson’s one-shot COVID-19 vaccine appears to provide more protection against worrisome virus variants than initially reported. The vaccine was developed in a collaboration between Johnson & Johnson and Beth Israel Deaconess Medical Center (BIDMC), led by Dan Barouch, MD, PhD of BIDMC. (ABC News, February 25, 2021)
Kevin Tabb, MD, President & CEO of Beth Israel Lahey Health, joined leadership from local hospitals on the ‘Future of Health Care’ panel and noted health care is moving beyond the four walls of a hospital to any place it’s needed including physician’s offices, community health centers, or a patient’s home. (Boston Business Journal, February 25, 2021)
Beth Israel Lahey Health announced it will resume offering limited new appointments for the COVID-19 vaccine to patients who are eligible under the current phase of the state’s distribution plan. (Boston Globe, February 24, 2021)
A research team at Beth Israel Deaconess Medical Center (BIDMC), led by James E. Kirby, MD of BIDMC and Ramy Arnaout, MD of BIDMC, has developed a mathematical model to estimate the false negative rate for COVID-19 tests. (Healthcare IT News, February 23, 2021)